Seeking Alpha

Acorda Therapeutics (ACOR): Q4 EPS of $0.40 may not be comparable to consensus of $0.24. Revenue...

Acorda Therapeutics (ACOR): Q4 EPS of $0.40 may not be comparable to consensus of $0.24. Revenue of $72.6M (+7.2% Y/Y) beats by $3.5M. (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)